Proffitt & Goodson’s Thermo Fisher Scientific TMO Stock Holding History

Proffitt & Goodson’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$55.1K	Buy	110 +13	+13%	+$6.24K	0.01%	187
2026 Q1	$47.7K	Hold	97	–	–	0.01%	182
2025 Q4	$56.2K	Sell	97 -8	-8%	-$4.52K	0.01%	168
2025 Q3	$50.9K	Buy	105 +8	+8%	+$3.72K	0.01%	168
2025 Q2	$39.3K	Hold	97	–	–	0.01%	174
2025 Q1	$48.3K	Hold	97	–	–	0.01%	162
2024 Q4	$50.5K	Sell	97 -2	-2%	-$1.1K	0.01%	161
2024 Q3	$61.2K	Sell	99 -27	-21%	-$16K	0.01%	160
2024 Q2	$69.7K	Buy	126 +29	+30%	+$16.6K	0.01%	156
2024 Q1	$56.4K	Hold	97	–	–	0.01%	155
2023 Q4	$51.5K	Hold	97	–	–	0.01%	150
2023 Q3	$49.1K	Hold	97	–	–	0.01%	150
2023 Q2	$50.6K	Hold	97	–	–	0.01%	150
2023 Q1	$55.9K	Hold	97	–	–	0.01%	152
2022 Q4	$53.4K	Hold	97	–	–	0.01%	158
2022 Q3	$49K	Hold	97	–	–	0.01%	162
2022 Q2	$53K	Hold	97	–	–	0.01%	166
2022 Q1	$57K	Hold	97	–	–	0.01%	172
2021 Q4	$65K	Hold	97	–	–	0.01%	152
2021 Q3	$55K	Hold	97	–	–	0.01%	154
2021 Q2	$49K	Hold	97	–	–	0.01%	162
2021 Q1	$44K	Hold	97	–	–	0.01%	166
2020 Q4	$45K	Hold	97	–	–	0.01%	159
2020 Q3	$43K	Hold	97	–	–	0.01%	148
2020 Q2	$35K	Buy	+97	New	+$32.5K	0.01%	159

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Proffitt & Goodson's TMO Position: Q2 2026 in Review

Proffitt & Goodson increased its Thermo Fisher Scientific (TMO) stake by 13% in Q2 2026, buying an estimated $6.24K and bringing the position to 110 shares worth $55.1K. The position accounts for 0.01% of the portfolio, ranked #187.

Proffitt & Goodson first reported a position in TMO in Q2 2020 and has held it in 25 quarters since. The position peaked at $69.7K in Q2 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Proffitt & Goodson held 110 shares of Thermo Fisher Scientific worth $55.1K as of Q2 2026.
Proffitt & Goodson bought 13 Thermo Fisher Scientific shares in Q2 2026, an estimated $6.24K.
Thermo Fisher Scientific made up 0.01% of Proffitt & Goodson's portfolio in Q2 2026, its #187 holding.
Proffitt & Goodson first reported a position in Thermo Fisher Scientific in Q2 2020 and has held it in 25 quarters since.
Proffitt & Goodson's Thermo Fisher Scientific position peaked at $69.7K in Q2 2024.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Proffitt & Goodson's 13F filing for Q2 2026, filed 22 Jul 2026.